MAXALT-MLT - 0006-3801-18 - (rizatriptan benzoate)

Alphabetical Index


Drug Information of MAXALT-MLT

Product NDC: 0006-3801
Proprietary Name: MAXALT-MLT
Non Proprietary Name: rizatriptan benzoate
Active Ingredient(s): 10    mg/1 & nbsp;   rizatriptan benzoate
Administration Route(s): ORAL
Dosage Form(s): TABLET, ORALLY DISINTEGRATING
Coding System: National Drug Codes(NDC)

Labeler Information of MAXALT-MLT

Product NDC: 0006-3801
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020865
Marketing Category: NDA
Start Marketing Date: 19980629

Package Information of MAXALT-MLT

Package NDC: 0006-3801-18
Package Description: 6 CONTAINER in 1 CARTON (0006-3801-18) > 3 POUCH in 1 CONTAINER > 1 BLISTER PACK in 1 POUCH (0006-3801-01) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

NDC Information of MAXALT-MLT

NDC Code 0006-3801-18
Proprietary Name MAXALT-MLT
Package Description 6 CONTAINER in 1 CARTON (0006-3801-18) > 3 POUCH in 1 CONTAINER > 1 BLISTER PACK in 1 POUCH (0006-3801-01) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Product NDC 0006-3801
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name rizatriptan benzoate
Dosage Form Name TABLET, ORALLY DISINTEGRATING
Route Name ORAL
Start Marketing Date 19980629
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name RIZATRIPTAN BENZOATE
Strength Number 10
Strength Unit mg/1
Pharmaceutical Classes Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Complete Information of MAXALT-MLT


General Information